The Latest in Multiple Sclerosis

Neurology Reviews

Switch From Fingolimod to Alemtuzumab Might Trigger MS Relapse

March 3, 2017

Multiple Sclerosis

Neurology Reviews

Relatives of Patients With MS Show Early Signs of Disease

March 3, 2017

Multiple Sclerosis

Clinical Neurology News

Humira Pen topped per-person drug spending in 2016

February 28, 2017

Neurology Reviews

Ocrelizumab Reduces Disease Progression in MS

January 30, 2017

Multiple Sclerosis

Neurology Reviews

Treatment Reduces Risk of Long-Term Disability in MS

January 27, 2017

Multiple Sclerosis

Clinical Neurology News

New report highlights gaps in knowledge on marijuana use

January 21, 2017

Clinical Neurology News

Switch from fingolimod to alemtuzumab might trigger MS relapse

January 19, 2017

Multiple Sclerosis

Clinical Neurology News

High-risk relatives of MS patients show early signs of disease

January 17, 2017

Multiple Sclerosis

Neurology Reviews

Rituximab May Have Advantages Over Fingolimod and Natalizumab in MS

December 28, 2016

Multiple Sclerosis

Neurology Reviews

What Are the Best Treatments for Bladder Dysfunction in MS?

December 27, 2016

Multiple Sclerosis

Clinical Neurology News

Lack of natalizumab concentration increase before PML argues against extending dosing interval

December 14, 2016

Multiple Sclerosis

Clinical Neurology News

Nomogram predicts conversion of first demyelinating event to definite MS

December 5, 2016

Multiple Sclerosis

Neurology Reviews

Which Factors Predict Relapse Freedom After Cessation of MS Treatment?

November 28, 2016

Multiple Sclerosis

Neurology Reviews

What Do We Know About Pediatric MS?

November 28, 2016

Neurology Reviews

Higher Latitude Is Associated With Earlier Age of MS Onset

November 28, 2016

Multiple Sclerosis